Please login to the form below

Not currently logged in
Email:
Password:

CROS NT names Mark Paul as senior VP of US operations

He joins from Veracity Logic

CROS NTInternational contract research organisation CROS NT has appointed Mark Paul as senior vice president of its US operations.

Paul will be responsible for the company's workings in the US and will represent US interests on the global leadership team.

Commenting on his appointment, Paul said: “I am looking forward to joining CROS NT; the company has a great reputation and a strong team in the US and I am looking forward to working with them and helping the business to grow here. 

“CROS NT has built up a portfolio of business through a combination of strong expertise and excellent customer service; I will continue to grow the US operation with those values in mind”.

Paul brings a wealth of experience to the role and has served in senior management roles at Quintiles, Health Decisions, StatWorks and most recently at Veracity Logic.

Andrew MacGarvey, CEO of CROS NT, added: “I am delighted to welcome Mark to our company. We are growing our customer base in the United States and increasing the size of our group here. 

“Mark has great experience in delivering global projects and in growing and developing operational teams. He will oversee our continued growth in the region and will work closely with our customers to ensure they receive the highest levels of service."


18th June 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics